Wayland, MA, United States of America

Wenfang Sybil Wu

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Berg LLC, Bpgbio, Inc.. Active years: 2020-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wenfang Sybil Wu. Retrieved from https://idiyas.com/inventor/wenfang-sybil-wu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Wenfang Sybil Wu

Introduction

Wenfang Sybil Wu is an accomplished inventor based in Wayland, MA, with a focus on biotechnological advancements. He holds two patents that contribute significantly to the field of medical diagnostics, particularly in relation to prostate cancer.

Latest Patents

Wu's latest patents revolve around filamin A (FLNA) binding proteins and their applications. The inventions encompass antibodies to FLNA, which can be either full-length antibodies or antigen-binding portions. These antibodies are designed for use in methods of diagnosis, monitoring, and prognosis of prostate cancer, showcasing Wu's commitment to advancing cancer research and treatment.

Career Highlights

Throughout his career, Wu has worked with notable companies such as Berg LLC and Bpgbio, Inc. His experience in these organizations has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Wu has collaborated with professionals like Shobha Ravipaty and Tracey Friss, contributing to a dynamic work environment that fosters innovation and creativity.

Conclusion

Wenfang Sybil Wu's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant inventor in medical diagnostics. His work continues to pave the way for advancements in cancer treatment and research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…